Loading...
XETRHNL
Market cap47mUSD
Dec 23, Last price  
7.60EUR
1D
1.06%
1Q
-36.67%
Jan 2017
-73.11%
IPO
-17.39%
Name

Dr Hoenle AG

Chart & Performance

D1W1MN
XETR:HNL chart
P/E
—
P/S
0.43
EPS
—
Div Yield, %
0.27%
Shrs. gr., 5y
1.92%
Rev. gr., 5y
-3.41%
Revenues
106m
-15.95%
22,418,00022,822,000026,246,00048,744,00044,985,00054,624,00067,878,00072,092,00077,273,00082,090,00092,173,00093,415,000101,926,000126,492,000107,747,00093,876,000115,170,000126,529,000106,342,000
Net income
-11m
L-16.61%
2,205,0002,708,00003,167,0004,569,000-4,083,0004,806,0006,879,0005,848,0006,620,0006,256,00010,128,0008,278,00010,427,00021,738,00012,477,0005,678,000-4,860,000-13,198,000-11,006,000
CFO
3m
P
1,748,0001,788,0004,326,0005,275,0001,886,000-3,096,0004,644,00010,293,0003,624,0005,363,0007,492,0009,159,0008,356,0006,579,00024,216,00016,924,0007,234,0001,130,000-7,406,0003,143,000
Dividend
Mar 25, 20220.2 EUR/sh
Earnings
Jan 28, 2025

Profile

Dr. Hönle AG supplies industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, medical technology, optics and opto electronics, automotive, and glass processing. The Equipment & Systems segment engages in the drying of inks and coatings, curing of adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.
URL
https://www.hoenle.de/
IPO date
Feb 25, 2008
Employees
581
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
106,342
-15.95%
126,529
9.86%
Cost of revenue
67,606
80,823
Unusual Expense (Income)
NOPBT
38,736
45,706
NOPBT Margin
36.43%
36.12%
Operating Taxes
273
1,652
Tax Rate
0.70%
3.61%
NOPAT
38,463
44,054
Net income
(11,006)
-16.61%
(13,198)
171.56%
Dividends
(123)
(1,212)
Dividend yield
0.11%
1.38%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
13,748
27,782
Long-term debt
45,753
34,953
Deferred revenue
63
115
Other long-term liabilities
3,391
4,341
Net debt
43,588
48,835
Cash flow
Cash from operating activities
3,143
(7,406)
CAPEX
(2,934)
(4,309)
Cash from investing activities
2,651
(1,692)
Cash from financing activities
(3,417)
3,731
FCF
51,589
49,358
Balance
Cash
9,317
7,131
Long term investments
6,596
6,769
Excess cash
10,596
7,574
Stockholders' equity
54,163
71,879
Invested Capital
145,886
161,337
ROIC
25.04%
26.75%
ROCE
24.57%
26.90%
EV
Common stock shares outstanding
6,062
6,062
Price
17.95
23.96%
14.48
-64.55%
Market cap
108,810
23.96%
87,776
-64.55%
EV
152,712
136,968
EBITDA
48,680
60,179
EV/EBITDA
3.14
2.28
Interest
1,816
1,528
Interest/NOPBT
4.69%
3.34%